Idiopathic progressive neuropathy

G6_IPNEUROP

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G60.3
  • Hospital discharge: ICD-9 3564A
  • Cause of death: ICD-10 G60.3
  • Cause of death: ICD-9 3564A

2 out of 7 registries used, show all original rules.

56

4. Check minimum number of events

None

56

5. Include endpoints

None

56

6. Filter based on genotype QC (FinnGen only)

53

Control definitions (FinnGen only)

Control exclude
G6_POLYNEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G60
Name in latin
Neuropathia progressiva idiopathica

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 509 207 286
Only index persons 283 119 164
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.00 0.01
Median age at first event (years)
Whole population 66.12 66.65 65.56
Only index persons 57.39 56.76 57.85

-FinnGen-

Key figures

All Female Male
Number of individuals 53 21 32
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 57.45 58.46 56.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
56
Matched controls
560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G60.3
ICD-10 Finland
Idiopathic progressive neuropathy
+∞
43.5
36
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
+∞
26.1
23
*
3564A
ICD-9 Finland
Hereditary and idiopathic peripheral neuropathy, Idiopathic progressive polyneuropathy
+∞
22.4
20
*
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
+∞
10.8
10
*
N03AX16
ATC
[U] pregabalin
5.3
8.3
24
70
G62.8
ICD-10 Finland
Other specified polyneuropathies
+∞
7.4
7
*
SPAT1236
SPAT
Informing family of child’s disability
35.0
7.4
9
*
N03AE01
ATC
clonazepam; systemic
12.1
6.4
11
11
G60.9
ICD-10 Finland
Hereditary and idiopathic neuropathy, unspecified
+∞
6.4
6
*
N03AX12
ATC
[U] gabapentin; oral
4.5
6.3
20
61
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
17.5
6.1
9
6

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
18
8.16
5.61
2.8
2.2
—
—
—
0
0
27
127
3.17
4.28
3.4
3.2
0.06
0.33
e6/l
1.27
22
101
9
14
7.42
4.17
6.6
4.8
—
—
—
0
0
7
7
11.19
4.13
4.4
5.3
7.50
8.40
mmol/l
—
7
7
13
35
4.52
3.92
3.9
4.1
4.77
4.58
kpa
0.13
13
35
7
8
9.78
3.89
4.4
4.8
1.73
1.49
mmol/l
—
7
8
25
120
2.96
3.73
3.2
3.3
—
—
—
0
0
13
39
4.02
3.52
4.2
3.9
5.90
5.37
kpa
0.85
13
39
10
25
4.63
3.27
3.5
3.0
133.10
121.88
g/l
—
10
25
29
161
2.66
3.18
3.9
4.1
10.34
46.69
e6/l
1.66
24
121
9
21
4.89
3.15
3.9
4.1
26.96
23.20
mmol/l
—
9
21
6
9
7.30
2.94
8.2
6.1
—
—
—
0
0
42
289
2.81
2.87
6.2
4.4
—
—
—
0
0
11
35
3.66
2.84
1.3
2.5
—
—
—
0
0
11
37
3.44
2.67
1.4
3.4
68.68
67.86
g/l
0.13
11
31
5
8
6.72
2.42
1.0
1.1
—
—
—
0
0
12
48
2.91
2.37
2.0
2.0
—
—
—
0
0
20
105
2.41
2.34
2.9
2.9
4.27
4.14
e6/l
0.04
20
94
6
13
5.03
2.34
1.0
1.2
—
—
—
0
0
18
90
2.47
2.33
5.8
5.3
1.01
1.02
kg/l
—
9
11
23
133
2.24
2.13
4.8
4.7
—
—
—
0
0
12
51
2.72
2.12
1.7
1.3
—
—
—
0
0
11
46
2.73
2.00
1.8
1.7
—
—
—
0
0
29
189
2.11
1.96
5.5
5.7
—
—
—
0
0
7
23
3.33
1.87
3.1
2.8
0.83
0.74
%
—
7
23
7
23
3.33
1.87
3.1
2.8
1.11
1.20
%
—
7
23
29
199
1.95
1.62
5.7
5.0
58.20
57.77
%
0.08
29
192
29
200
1.93
1.59
5.7
5.2
25.21
26.93
%
0.36
29
192
7
27
2.81
1.57
3.1
2.0
14.33
9.77
g/l
—
7
22
17
98
2.05
1.53
4.7
3.2
552.53
581.64
mosm/kgh2o
0.21
17
83
36
271
1.92
1.48
3.6
4.7
6.74
6.70
mmol/l
0.03
36
256
14
76
2.12
1.46
1.9
1.4
3.19
3.44
g/l
—
9
40
28
195
1.87
1.46
5.7
5.1
2.66
2.77
%
0.11
28
186
28
196
1.86
1.42
5.9
5.4
9.24
8.75
%
0.31
28
187
9
42
2.36
1.41
3.3
3.8
—
—
—
0
0
11
56
2.20
1.33
1.4
1.3
1.32
3.82
u/ml
—
6
21
18
112
1.89
1.29
1.6
1.5
17.60
21.00
nmol/l
0.31
18
95
6
25
2.56
1.28
2.0
1.3
2.10
1.12
g/l
—
6
19
18
115
1.83
1.18
5.9
3.8
—
—
—
0
0
9
47
2.09
1.09
1.2
1.5
—
—
—
0
0
21
146
1.70
1.03
6.3
4.5
—
—
—
0
0
7
36
2.08
1.01
1.6
4.9
1.27
1.60
mmol/l
—
7
36
10
55
2.00
0.99
1.8
2.0
—
—
—
0
0
6
27
2.36
0.97
2.2
3.8
0.23
0.13
e6/l
—
6
27
8
42
2.05
0.93
1.3
1.4
—
—
—
0
0
6
29
2.19
0.92
5.2
4.2
—
—
—
0
0
8
45
1.90
0.89
2.1
1.5
—
—
—
0
0
24
180
1.58
0.85
2.2
1.9
98.53
93.50
pmol/l
0.24
18
91
18
127
1.62
0.81
5.0
3.1
—
—
—
0
0
18
129
1.58
0.76
2.1
2.3
—
—
—
0
0
7
39
1.91
0.76
3.4
6.1
—
—
—
0
0
9
58
1.66
0.74
3.2
6.9
104.00
104.36
mmol/l
—
9
58
16
113
1.58
0.71
2.6
2.9
304.00
4160.26
umol/l
0.51
16
85
26
314
0.68
0.67
4.0
4.1
—
—
—
0
0
7
47
1.56
0.50
2.0
2.7
7.29
10.17
umol/l
—
7
38
5
34
1.52
0.41
1.2
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
2.2
—
7.79
—
0
17
0
17
0.00
0.41
0.0
2.2
—
2.98
—
0
11
0
17
0.00
0.41
0.0
2.2
—
5.31
—
0
17
6
45
1.37
0.35
2.7
4.6
—
—
—
0
0
6
46
1.34
0.34
2.5
1.7
389.33
358.28
nmol/l
—
6
40
7
52
1.39
0.33
1.4
1.3
—
—
—
0
0
45
474
0.74
0.29
33.7
23.0
30.32
30.40
pg
0.11
45
468
45
474
0.74
0.29
33.9
23.2
130.73
134.16
g/l
1.03
45
468
45
473
0.75
0.27
33.9
23.1
242.29
243.72
e9/l
0.04
45
465
45
473
0.75
0.27
33.8
23.1
91.18
91.38
fl
0.09
45
467
5
42
1.21
0.22
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
3.8
—
—
—
0
0
0
14
0.00
0.20
0.0
20.8
—
—
—
0
0
39
367
1.21
0.20
23.8
19.3
14.29
14.97
%
0.49
39
362
15
129
1.22
0.19
3.4
4.3
—
7.40
—
0
30
11
93
1.23
0.16
1.5
1.4
—
—
—
0
0
16
143
1.17
0.13
3.0
3.3
—
—
—
0
0
15
167
0.86
0.13
2.3
2.1
—
—
—
0
0
12
109
1.13
0.07
8.8
7.4
—
—
—
0
0
44
446
0.94
0.01
19.7
15.9
—
—
—
0
0
45
449
1.01
0.00
25.8
18.5
139.80
139.58
mmol/l
0.26
45
433
45
451
0.99
0.00
25.2
18.3
3.96
4.02
mmol/l
0.71
45
435
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
0.73
—
0
6
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
11.28
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
8.90
—
0
5
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
9
92
0.97
-0.00
8.8
4.1
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
4.33
—
0
7
0
5
0.00
-0.00
0.0
3.0
—
9.96
—
0
5
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
90.01
—
0
8
0
5
0.00
-0.00
0.0
14.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
60.57
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_IPNEUROP and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_IPNEUROP.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: G6_IPNEUROP – Idiopathic progressive neuropathy

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data